These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 14993244)

  • 41. Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes.
    Colhoun HM; Taskinen MR; Otvos JD; Van Den Berg P; O'Connor J; Van Tol A
    Diabetes; 2002 Nov; 51(11):3300-5. PubMed ID: 12401722
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Role of lipid transfers in intravascular lipoprotein metabolism in human].
    Gambert P
    C R Seances Soc Biol Fil; 1995; 189(5):883-8. PubMed ID: 8673633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Introduction of the human PLTP transgene suppresses the atherogenic diet-induced increase in plasma phospholipid transfer activity in C57BL/6 mice.
    Tu AY; Paigen B; Wolfbauer G; Cheung MC; Kennedy H; Chen H; Albers JJ
    Int J Clin Lab Res; 1999; 29(1):14-21. PubMed ID: 10356658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased plasma cholesterol esterification and cholesteryl ester transfer in hypopituitary patients on glucocorticoid replacement therapy.
    Beentjes JA; van Tol A; Sluiter WJ; Dullaart RP
    Scand J Clin Lab Invest; 2000 May; 60(3):189-98. PubMed ID: 10885490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phospholipid transfer protein.
    van Tol A
    Curr Opin Lipidol; 2002 Apr; 13(2):135-9. PubMed ID: 11891415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins.
    Qin S; Kawano K; Bruce C; Lin M; Bisgaier C; Tall AR; Jiang X
    J Lipid Res; 2000 Feb; 41(2):269-76. PubMed ID: 10681411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia.
    Guérin M; Le Goff W; Lassel TS; Van Tol A; Steiner G; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):282-8. PubMed ID: 11156866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipid transfer proteins: past, present and perspectives.
    Quintão EC; Cazita PM
    Atherosclerosis; 2010 Mar; 209(1):1-9. PubMed ID: 19733354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factor.
    Tzotzas T; Desrumaux C; Lagrost L
    Obes Rev; 2009 Jul; 10(4):403-11. PubMed ID: 19413703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel roles of hepatic lipase and phospholipid transfer protein in VLDL as well as HDL metabolism.
    van Haperen R; Samyn H; van Gent T; Zonneveld AJ; Moerland M; Grosveld F; Jansen H; Dallinga-Thie GM; van Tol A; de Crom R
    Biochim Biophys Acta; 2009 Oct; 1791(10):1031-6. PubMed ID: 19524061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein (CETP) in CETP transgenic/ApoCI-knocked out mice.
    Gautier T; Masson D; Jong MC; Duverneuil L; Le Guern N; Deckert V; Pais de Barros JP; Dumont L; Bataille A; Zak Z; Jiang XC; Tall AR; Havekes LM; Lagrost L
    J Biol Chem; 2002 Aug; 277(35):31354-63. PubMed ID: 12070157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
    Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma phospholipid transfer activity is essential for increased atherogenesis in PLTP transgenic mice: a mutation-inactivation study.
    Samyn H; Moerland M; van Gent T; van Haperen R; Metso J; Grosveld F; Jauhiainen M; van Tol A; de Crom R
    J Lipid Res; 2008 Dec; 49(12):2504-12. PubMed ID: 18711210
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia.
    Le Goff W; Guerin M; Chapman MJ
    Pharmacol Ther; 2004 Jan; 101(1):17-38. PubMed ID: 14729390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phospholipid transfer protein is present in human tear fluid.
    Jauhiainen M; Setälä NL; Ehnholm C; Metso J; Tervo TM; Eriksson O; Holopainen JM
    Biochemistry; 2005 Jun; 44(22):8111-6. PubMed ID: 15924430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate.
    Bouly M; Masson D; Gross B; Jiang XC; Fievet C; Castro G; Tall AR; Fruchart JC; Staels B; Lagrost L; Luc G
    J Biol Chem; 2001 Jul; 276(28):25841-7. PubMed ID: 11342537
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Worsening of diet-induced atherosclerosis in a new model of transgenic rabbit expressing the human plasma phospholipid transfer protein.
    Masson D; Deckert V; Gautier T; Klein A; Desrumaux C; Viglietta C; Pais de Barros JP; Le Guern N; Grober J; Labbé J; Ménétrier F; Ripoll PJ; Leroux-Coyau M; Jolivet G; Houdebine LM; Lagrost L
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):766-74. PubMed ID: 21252068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin.
    Lagrost L; Athias A; Lemort N; Richard JL; Desrumaux C; Châtenet-Duchêne L; Courtois M; Farnier M; Jacotot B; Braschi S; Gambert P
    Atherosclerosis; 1999 Apr; 143(2):415-25. PubMed ID: 10217372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated expression of PLTP is atherogenic in apolipoprotein E deficient mice.
    van Haperen R; van Gent T; van Tol A; de Crom R
    Atherosclerosis; 2013 Mar; 227(1):37-42. PubMed ID: 23313246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of plasma phospholipid transfer protein activity with IDL and buoyant LDL: impact of gender and adiposity.
    Cheung MC; Knopp RH; Retzlaff B; Kennedy H; Wolfbauer G; Albers JJ
    Biochim Biophys Acta; 2002 May; 1587(1):53-9. PubMed ID: 12009424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.